- £13.86bn
- £13.25bn
- £964.20m
- 71
- 22
- 100
- 74
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 178 | 303 | 421 | 560 | 964 |
Cost of Revenue | |||||
Gross Profit | 110 | 188 | 261 | 372 | 638 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Operating Interest Expense / Income | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 166 | 279 | 376 | 511 | 807 |
Operating Profit | 12.2 | 23.6 | 44.9 | 48.7 | 157 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 10.1 | 20.4 | 41.1 | 43.9 | 147 |
Provision for Income Taxes | |||||
Net Income After Taxes | 10.3 | 15 | 30.9 | 32.9 | 114 |
Net Income Before Extraordinary Items | |||||
Net Income | 10.3 | 15 | 30.9 | 32.9 | 114 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 10.3 | 15 | 30.9 | 32.9 | 114 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.007 | 0.011 | 0.024 | 0.037 | 0.109 |
Dividends per Share |